Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
meeting crawled time : 16:00 save search
TFI International to Hold Annual Meeting of Shareholders
Published: 2024-04-18 (Crawled : 16:00) - globenewswire.com
TFII | $141.65 -1.86% 0.0% 360K
|
Transportation
|
| O: 0.49%
H: 0.0%
C: 0.0%
international meeting
Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 16:00) - globenewswire.com
APRE | $5.73 -1.29% 870
|
Health Technology
|
| O: -2.14%
H: 4.91%
C: 4.91%
apr-1051 meeting therapeutics
Summary of FLSmidth & Co. A/S' Annual General Meeting
Published: 2024-04-10 (Crawled : 16:00) - globenewswire.com
FLIDY | $4.53 19.1% 150
|
Manufacturing
| Email alert
Add to watchlist
FLIDF | $50.45 1.2K
|
Non-Energy Minerals
| Email alert
Add to watchlist
meeting
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-04-09 (Crawled : 16:00) - globenewswire.com
CMPX | $1.5 -1.96% -2.0% 240K
|
Professional, Scientific, and T...
|
| O: 2.06%
H: 0.0%
C: 0.0%
association tumors cancer research for meeting therapeutics negative
Medicenna Presents Updated Preclinical Data on MDNA113, a First-in-Class, Targeted and Masked Bi-functional anti-PD1-IL2 Superkine, at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
Published: 2024-04-09 (Crawled : 16:00) - globenewswire.com
MDNAF | $1.27 -17.54% 140K
|
n/a
|
| O: -3.82%
H: 0.0%
C: -13.49%
mdna113 association cancer research preclinical for meeting
Rallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual Meeting
Published: 2024-04-01 (Crawled : 16:00) - biospace.com/
RLYB | News | $1.68 -4.55% -4.76% 350K
|
|
| O: -4.86%
H: 0.0%
C: 0.0%
review meeting
Kiora Pharmaceuticals to Present Additional Data from Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting
Published: 2024-03-28 (Crawled : 16:00) - biospace.com/
KPRX | $0.4913 -2.94% -3.03% 160K
|
Manufacturing
|
| O: -2.26%
H: 20.0%
C: 17.67%
pharmaceuticals meeting trial
PARCHMENT INTRODUCES LEARNER-CENTERED DIPLOMA SOLUTION FOR K-12 SCHOOLS AND DISTRICTS TO MEET THE NEEDS OF A DIGITAL WORLD
Published: 2024-02-27 (Crawled : 16:00) - prnewswire.com
INST | $19.22 0.1% 0.0% 190K
|
|
| O: 0.17%
H: 0.26%
C: -0.48%
solution world
Canterbury Park Announces Pre-Paid Starter Incentive Program to Assist in Recruiting Trainers for 2024 Race Meet
Published: 2024-02-14 (Crawled : 16:00) - canterburypark.com
CPHC | $23.25 -0.17% -0.17% 1.7K
|
Consumer Services
|
| O: 1.55%
H: 0.09%
C: 0.09%
program
Energem Corp and Graphjet Technology Sdn. Bhd. Announce Effectiveness of Registration Statement and Date of Energem Corp’s Shareholder Meeting to Approve Proposed Business Combination
Published: 2024-02-05 (Crawled : 16:00) - globenewswire.com
ENCP | $12.25 -0.41% 22K
|
n/a
| Email alert
Add to watchlist
business meeting technology
Northann Corp. to Meet Investors, Present Latest 3D Printing Ecosystem and Sustainable Products at TISE2024 in Las Vegas January 24th – 26th, 2024
Published: 2024-01-03 (Crawled : 16:00) - globenewswire.com
NCL | News | $0.495 5.32% 0.0% 59K
|
|
| O: -0.83%
H: 0.0%
C: -11.2%
tise2024
Avenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
Published: 2023-12-01 (Crawled : 16:00) - biospace.com/
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 4.55%
H: 7.25%
C: 4.83%
ATXI | $0.1311 -2.96% -3.05% 290K
|
Health Technology
|
| O: -10.57%
H: 11.08%
C: 1.27%
meeting therapeutics
Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 Annual Meeting
Published: 2023-12-01 (Crawled : 16:00) - biospace.com/
STOK | News | $11.66 -0.51% -0.51% 1.1M
|
Health Technology
|
| O: 1.32%
H: 4.95%
C: 2.86%
children meeting therapeutics
Jazz Pharmaceuticals to Present New Data Highlighting Advancements in Solid Tumors and Rare Blood Cancers at Upcoming Oncology Meetings
Published: 2023-11-30 (Crawled : 16:00) - biospace.com/
JAZZ | News | $109.3 2.05% 2.01% 560K
|
Health Technology
|
| O: -0.16%
H: 3.85%
C: 3.64%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 1.92%
H: 1.34%
C: 0.16%
rare tumors blood pharmaceuticals
Pharvaris Presents Deucrictibant Clinical Data and Real-World HAE Treatment Satisfaction Data at ACAAI 2023 Annual Scientific Meeting
Published: 2023-11-09 (Crawled : 16:00) - globenewswire.com
PHVS | $18.5 -12.74% -14.59% 69K
|
|
| O: -1.16%
H: 0.0%
C: -1.47%
treatment meeting
Aligos Therapeutics to Present Multiple Posters at AASLD’s The Liver Meeting® 2023, Highlighting Progress for Its Clinical Stage Portfolio
Published: 2023-11-07 (Crawled : 16:00) - biospace.com/
ALGS | $0.781 -0.76% -0.77% 240K
|
Health Technology
|
| O: 5.13%
H: 0.13%
C: -7.88%
meeting liver therapeutics
Waterproofing Demands Propel Europe Construction Silicones Market Growth, Meeting Requirements for Moisture Protection
Published: 2023-11-06 (Crawled : 16:00) - prnewswire.com
DKILF | $126.0 25.48% 640
|
Producer Manufacturing
|
| O: 8.98%
H: 0.0%
C: -2.57%
SHECF | $41.618 176.84% 1.2K
|
Process Industries
|
| O: 4.47%
H: 0.13%
C: -3.76%
DKILY | $12.49 -0.07% 340K
|
Manufacturing
|
| O: 0.26%
H: 1.31%
C: -0.2%
SHECY | $20.46 -1.38% 130K
|
Manufacturing
|
| O: -4.81%
H: 4.99%
C: 2.62%
PPG A | $135.11 0.11% -0.82% 2.3M
|
Process Industries
|
| O: -0.23%
H: 0.91%
C: -0.21%
europe propel construction meeting market
IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
INAB | $1.04 4.0% 3.85% 130K
|
|
| O: 4.0%
H: 5.77%
C: 0.0%
positive update cancer cell immunotherapy meeting platform
Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Targeting Claudin18.2 at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: 5.39%
H: 16.45%
C: 11.82%
candidate cancer preclinical immunotherapy meeting therapeutics
Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: 5.39%
H: 16.45%
C: 11.82%
cancer preclinical immunotherapy meeting therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.